Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Drug Alcohol Depend. 2011 Nov 27;123(1-3):148–153. doi: 10.1016/j.drugalcdep.2011.11.001

Table 1.

Cannabinoid receptor binding and in vivo effects of 1-pentyl-3-phenylacetylindoles, unsubstituted and with methyl and methoxy substituents at various positions on the phenyl ring.

Compound * R * R′ Affinities (nM)a In Vivo ED50s (μmol/kg)** Avg. Potency
CB1 CB2 SA %MPE RT
Δ9-THC ----- ----- 41b (2) 36c (10) 0.9 d 2.6 d 2.6 d 2.0
JWH-018 Naphthoyl H 9d (5) 3 (3) 0.3d ~ 0.09d 1.8d 0.7

JWH-167 Phenyl H 90 (17) 159 (14) 1.6 (0.9–2.6) 1.3 (0.7–2.3) 13 (7–23) 5.3
JWH-205 Phenyl CH3 134 (23) 180 (9) 19 (9–34) 13 (9–19) 13 (9–16) 15

JWH-251 2-Methylphenyl H 29 (3) 146 (36) 0.9 (0.6–1.6) 0.9 (0.6–1.3) 6 (3–9) 2.6
JWH-252 2-Methylphenyl CH3 23 (3) 19 (0.6) NT NT NT ---

JWH-208 4-Methylphenyl H 179 (10) 570 (127) 2.8 (0.9–9) 16 (9–25) 38 (22–63) 18.9
JWH-209 4-Methylphenyl CH3 746 (49) 1353 (270) 39 (21–75) 57 (33–99) 81 (42–153) 59

JWH-250 2-Methoxyphenyl H 11 (2) 33 (3) NT NT NT ---
JWH-306 2-Methoxyphenyl CH3 25 (1) 82 (11) 87% (2.9 μg/kg) 1.1 (0.9–1.4) 1.1 (0.9–1.7) 1.1

JWH-302 3-Methoxyphenyl H 17 (2) 89 (15) 0.6 (0.3–1.2) 0.9 (0.6–1.2) 3 (2.1–4.2) 1.5
JWH-253 3-Methoxyphenyl CH3 62 (10) 33 (3) NT NT NT ---

JWH-201 4-Methoxyphenyl H 1064 (21) 444 (14) 84% (90 μg/kg) 35% (90 μg/kg) −2.3 (90 μg/kg) ---
JWH-202 4-Methoxyphenyl CH3 1678 (62) 645 (6) 26 (11–51) 51 (29–97) −2.5 (86 μg/kg) 38.5
*

See Figure 1.

**

SA = spontaneous activity, %MPE = % maximum possible antinociceptive effect, RT = rectal temperature, NT = not tested. Values shown are ED50s (95% confidence intervals). Single dose tests are indicated by magnitude of effect and dose (in parentheses). Average potency was calculated as the average of all ED50 values for the compound.

a

(Huffman et al., 2005a) CB1 and CB2 affinities of all 1-pentyl-3-phenylacetylindoles presented first in this publication. Values shown are Ki (± SEM).